This TGAS, tailored for the targeted inhibition of COX‐2, is capable of managing the multifaceted challenges inherent in cancer therapy, thereby illuminating the promising horizons for COX‐2‐targeted photodynamic dyes in the realms of diagnostic imaging and therapeutic intervention. The gene discussed is PTGS2; the disease is cancer.